Release Date: 31/10/19 17:11 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 274.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%